European Union’s strategy on endocrine disrupting chemicals and the current position of Slovenia
| Autor: | Tanja Fatur, Lucija Perharic, Jernej Drofenik |
|---|---|
| Rok vydání: | 2016 |
| Předmět: |
0301 basic medicine
Slovenia Guidelines as Topic Legislation Commission Endocrine Disruptors 010501 environmental sciences Toxicology Risk Assessment 01 natural sciences 03 medical and health sciences Humans media_common.cataloged_instance European Union European union 0105 earth and related environmental sciences media_common Public economics Public Health Environmental and Occupational Health Environmental Exposure Environmental exposure Hazard 030104 developmental biology Position (finance) Identification (biology) Business Element (criminal law) |
| Zdroj: | Archives of Industrial Hygiene and Toxicology. 67:99-105 |
| ISSN: | 0004-1254 |
| DOI: | 10.1515/aiht-2016-67-2728 |
| Popis: | In view of the European Union regulations 1107/2009 and 528/2012, which say that basic substances in plant protection and biocidal products marketed in the European Union (EU) should not have an inherent capacity to cause endocrine disruption, an initiative was started to define scientific criteria for the identification of endocrine disruptors (EDs). The objectives of the EU strategy on EDs are to protect human health and the environment, to assure the functioning of the market, and to provide clear and coherent criteria for the identification of EDs that could have broad application in the EU legislation. Policy issues were to be addressed by the Ad-hoc group of Commission Services, EU Agencies and Member States established in 2010, whereas the scientific issues were to be addressed by the Endocrine Disruptors Expert Advisory Group (ED EAG), established in 2011. The ED EAG adopted the 2002 World Health Organization (WHO) definition of endocrine disruptor and agreed that for its identification it is necessary to produce convincing evidence of a biologically plausible causal link between an adverse effect and endocrine disrupting mode of action. In 2014, the European Commission proposed four ED identification criteria options and three regulatory options, which are now being assessed for socio-economic, environmental, and health impact. Slovenia supports the establishing of identification criteria and favours option 4, according to which ED identification should be based on the WHO definition with the addition of potency as an element of hazard characterisation. As for regulatory options, Slovenia favours the risk-based rather than hazard-based regulation. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|